Definium Therapeutics Inc (DFTX)
SG&A Expense Growth
48.92%
Quarterly · Period ending:
DFTX SG&A Expense Growth
Latest reported48.92%period ending
Latest reported48.92%period ending
DFTX Quarterly SG&A Growth (QoQ) (0.00% → 48.92%)
Latest values, visible window
High-resolution chart · PNG
DFTX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 48.9175% | |
| 26.172% | |
| -4.3156% | |
| 32.4229% | |
| 26.0395% | |
| -17.7614% | |
| 40.7549% | |
| -22.511% | |
| -6.534% | |
| -1.5011% | |
| 26.6968% | |
| -41.6048% | |
| 74.3556% | |
| 62.9783% | |
| -44.9571% | |
| 20.9269% | |
| -7.8291% | |
| 23.8052% | |
| -18.6769% | |
| -77.9034% | |
| 451.5367% | |
| -9.0357% | |
| 245.6583% | |
| -32.7895% | |
| 38.8066% | |
| 0% | |
| 536.5826% | |
| 27.5766% | |
| 4.2835% | |
| -43.2495% | |
| -52.8525% | |
| 94.043% | |
| 45.4187% | |
| -23.9416% | |
| -47.5623% | |
| 47.5721% | |
| -10.7954% | |
| 0% |